Orelabrutinib in the Treatment of HP-positive Gastric MALT Lymphoma

Clinical trial NCT06228963 · RECRUITING

Trial details

NCT number: NCT06228963
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

MALT Lymphoma of Stomach Helicobacter Pylori Infection

Start date: 2024-03-01
Primary completion: 2026-01-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.